These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23619386)

  • 21. Proteasome deubiquitinases as novel targets for cancer therapy.
    D'Arcy P; Linder S
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1729-38. PubMed ID: 22819849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome.
    Desvergne A; Genin E; Maréchal X; Gallastegui N; Dufau L; Richy N; Groll M; Vidal J; Reboud-Ravaux M
    J Med Chem; 2013 Apr; 56(8):3367-78. PubMed ID: 23540790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel proteasome inhibitors to overcome bortezomib resistance.
    Ruschak AM; Slassi M; Kay LE; Schimmer AD
    J Natl Cancer Inst; 2011 Jul; 103(13):1007-17. PubMed ID: 21606441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasomal ATPase-associated factor 1 negatively regulates proteasome activity by interacting with proteasomal ATPases.
    Park Y; Hwang YP; Lee JS; Seo SH; Yoon SK; Yoon JB
    Mol Cell Biol; 2005 May; 25(9):3842-53. PubMed ID: 15831487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
    Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
    Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function.
    Oshiro N; Yoshino K; Hidayat S; Tokunaga C; Hara K; Eguchi S; Avruch J; Yonezawa K
    Genes Cells; 2004 Apr; 9(4):359-66. PubMed ID: 15066126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach.
    Groll M; Huber R
    Biochim Biophys Acta; 2004 Nov; 1695(1-3):33-44. PubMed ID: 15571807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
    Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
    Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Design, synthesis and biological assay of novel tripeptidic tetrazoles as inhibitors of 20S proteasome].
    Ma YH; Xu B; Cui JR; Yang ZJ; Zhang LR; Zhang LH
    Yao Xue Xue Bao; 2012 Apr; 47(4):472-8. PubMed ID: 22799029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells.
    Jarvius M; Fryknäs M; D'Arcy P; Sun C; Rickardson L; Gullbo J; Haglund C; Nygren P; Linder S; Larsson R
    Biochem Biophys Res Commun; 2013 Feb; 431(2):117-23. PubMed ID: 23318177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A tetrahedral transition state at the active sites of the 20S proteasome is coupled to opening of the alpha-ring channel.
    Osmulski PA; Hochstrasser M; Gaczynska M
    Structure; 2009 Aug; 17(8):1137-47. PubMed ID: 19679091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycin-induced nonalcoholic fatty liver.
    Chaveroux C; Eichner LJ; Dufour CR; Shatnawi A; Khoutorsky A; Bourque G; Sonenberg N; Giguère V
    Cell Metab; 2013 Apr; 17(4):586-98. PubMed ID: 23562079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its degradation in the ubiquitin-proteasome pathway.
    Zhou J; Wan B; Li R; Gu X; Zhong Z; Wang Y; Yu L
    Biochem Biophys Res Commun; 2012 Jun; 422(4):647-52. PubMed ID: 22609399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors.
    Sprangers R; Li X; Mao X; Rubinstein JL; Schimmer AD; Kay LE
    Biochemistry; 2008 Jul; 47(26):6727-34. PubMed ID: 18540636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1 and N5 derivatives of cerpegin: synthesis of a new series based on structure-activity relationships to optimize their inhibitory effect on 20S proteasome.
    Hovhannisyan A; Pham TH; Bouvier D; Qin L; Melikyan G; Reboud-Ravaux M; Bouvier-Durand M
    Bioorg Med Chem Lett; 2013 May; 23(9):2696-703. PubMed ID: 23541650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 20S proteasome as novel biological target for organochalcogenanes.
    Piovan L; Milani P; Silva MS; Moraes PG; Demasi M; Andrade LH
    Eur J Med Chem; 2014 Feb; 73():280-5. PubMed ID: 24463395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Fully Recombinant Human 20S and 20S-PA200 Proteasome Complexes.
    Toste Rêgo A; da Fonseca PCA
    Mol Cell; 2019 Oct; 76(1):138-147.e5. PubMed ID: 31473102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric coupling between α-rings of the 20S proteasome.
    Yu Z; Yu Y; Wang F; Myasnikov AG; Coffino P; Cheng Y
    Nat Commun; 2020 Sep; 11(1):4580. PubMed ID: 32917864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoenzymology of the 20S proteasome: proteasomal actions are controlled by the allosteric transition.
    Osmulski PA; Gaczynska M
    Biochemistry; 2002 Jun; 41(22):7047-53. PubMed ID: 12033938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PA28αβ reduces size and increases hydrophilicity of 20S immunoproteasome peptide products.
    Raule M; Cerruti F; Benaroudj N; Migotti R; Kikuchi J; Bachi A; Navon A; Dittmar G; Cascio P
    Chem Biol; 2014 Apr; 21(4):470-480. PubMed ID: 24631123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.